FAQ
Contraceptive Market Size Visualizer (CMSV)
Should I use the provincial or the district-level Subnational Market Size Estimator?
The Subnational Market Size Estimator displays different indicators depending on the administrative level selected.
At the provincial level, indicators are specific to the private sector. Users can view current private sector users of five contraceptive methods: injectable contraceptives, oral contraceptives, male condoms, implants, and intrauterine devices. The estimator also displays current public sector users of these methods who are estimated to have the financial capacity to obtain their method from a private source. Together, these two views help identify both the existing private market and the population most likely to transition to private sector sourcing.
At the district level, indicators are sector-agnostic and reflect the broader contraceptive landscape. These generally include the total number of modern contraceptive method users, short-term method users, long-acting reversible contraceptive (LARC) users, women with an unmet need or unmet demand for contraception, and injectable users disaggregated by method type: DMPA-IM and DMPA-SC. The specific indicators available at this level will vary by country depending on the availability and granularity of underlying data.
Why is the National Volume and Value Estimator providing estimates for the year 2026?
The National Volume and Value Estimator was designed to provide relevant potentials for the selected country for current or near-future considerations. The data was drawn from the modeling estimates from the national aggregate of the subnational market size and market price observations that were collected recently. As program and/or policy implementation does not take place immediately or in the recent past, we designed the tool to reflect imminent situations.
Why does the National Volume and Value Estimator not include all contraceptive methods?
The National Volume and Value Estimator includes several contraceptive methods that consist of the predominant method mix in that country. We excluded analysis of permanent contraceptive methods as the commodities required would not be recurring and such estimation would require a different estimation method. Although emergency contraceptive pills may be an important contraceptive method in some countries, previous research has shown that the conventional approach (used in the DHS survey) to measuring the use of emergency contraceptive pills largely underestimates its use in the past 12 months.¹ Due to the lack of reliable and representative data on the use of emergency contraceptive pills, we were unable to include this contraceptive method in this tool.
References:
- Larson E, Morzenti A, Guiella G, Gichangi P, Makumbi F, Choi Y. Reconceptualizing Measurement of Emergency Contraceptive Use: Comparison of Approaches to Estimate the Use of Emergency Contraception. Studies in Family Planning. 2020;51(1):87-102. doi:10.1111/sifp.12111
Why can’t I change the retail price for the National Volume and Value Estimator?
As the demand for various contraceptives is likely price-sensitive, adjusting the retail price would result in changes in demand for contraceptives in the private sector. The tool applied the private sector use for each contraceptive based on the nationally representative survey, in which the demand was based on the current market price of contraceptives. Given the lack of data on the price sensitivity of different contraceptive products in the selected country, the tool does not allow adjustment of the retail price for estimation.
If I am interested in the estimation of future use or cost of contraceptive commodities, are there other tools available?
M4M’s market sizing report for Ghana, produced under the USAID-funded Frontier Health Markets project.
CMSV
HOME
INTERPRETATION
The CMSV provides estimates of two different types of contraceptive market size: 1) subnational region and district level users, and 2) national level private sector users, volume, and value of contraceptives.
READ MOREMETHODOLOGY
Using nationally representative surveys, routine health service data, and high-resolution population data, the subnational market size estimation serves to illustrate the distribution of contraceptive users and those with contraceptive needs.
READ MOREEXAMPLE USE CASES
How can policy makers, private sector actors, donors, non-governmental organizations, advocates, and researchers use the CMSV?
READ MOREContact us to learn how Metrics for Management can help you use targeted, accurate, and measurable data to expand and improve your services.
GET IN TOUCHAIMS Partners
The CMSV is a product of the Advancing Injectable Markets for Sustainability (AIMS) project which is led by PATH in partnership with the Africa Resource Centre, Health Systems Insight, Metrics for Management, and Solina Centre for International Development and Research. Dedicated to improving women's choice and access to injectable contraception, AIMS is creating a sustainable market for DMPA-SC and self-injection, ensuring balanced supply and demand, with robust public- and private-sector access to contraceptive injectables for women living in low- and middle-income countries. For more www.FPoptions.org | FPoptions@path.org.
Metrics for Management © 2026 |
in


